• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆患者的死亡时间:对痴呆患者生存时间和生命损失年数的系统文献回顾。

Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia.

机构信息

Dementia Collaborative Research Centre, University of New South Wales, Sydney, NSW, Australia.

出版信息

Int Psychogeriatr. 2012 Jul;24(7):1034-45. doi: 10.1017/S1041610211002924. Epub 2012 Feb 13.

DOI:10.1017/S1041610211002924
PMID:22325331
Abstract

BACKGROUND

Life expectancy with dementia directly influences rates of prevalence and service needs and is a common question posed by families and patients. As well as years of survival, it is useful to consider years of life lost after a diagnosis of dementia.

METHODS

We systematically reviewed the literature on mortality and survival with dementia which were compared to estimated life expectancies in the general population. Both were then compared by age (under 65 years vs. 65+ years), gender, dementia type, severity, and two epochs (prior to and after introduction of cholinesterase inhibitors in 1997).

RESULTS

Survival after a diagnosis of dementia varies considerably and depends on numerous factors and their complex interaction. Relative loss of life expectancy decreases with age at diagnosis across varying gender, dementia subtypes (except for frontotemporal dementia and dementia with Lewy bodies), and severity stages. Numerous study deficiencies precluded a meta-analysis of survival in dementia.

CONCLUSION

Estimates of years of life lost through dementia may be helpful for patients and their families. Recommendations for future research methods are proposed.

摘要

背景

痴呆患者的预期寿命直接影响患病率和服务需求的比率,也是患者及其家属经常提出的问题。除了存活年限外,在诊断为痴呆后丧失的预期寿命也很有用。

方法

我们系统地回顾了痴呆患者的死亡率和生存率文献,将其与普通人群的预期寿命进行了比较。然后,我们根据年龄(<65 岁与≥65 岁)、性别、痴呆类型、严重程度以及两个时期(1997 年之前和之后引入乙酰胆碱酯酶抑制剂)进行了比较。

结果

痴呆诊断后的生存率差异很大,取决于许多因素及其复杂的相互作用。在不同性别、痴呆亚型(额颞叶痴呆和路易体痴呆除外)和严重程度阶段,随着诊断时年龄的增加,相对预期寿命损失减少。由于许多研究存在缺陷,因此无法对痴呆患者的生存率进行荟萃分析。

结论

通过痴呆估计丧失的预期寿命可能对患者及其家属有所帮助。提出了对未来研究方法的建议。

相似文献

1
Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia.痴呆患者的死亡时间:对痴呆患者生存时间和生命损失年数的系统文献回顾。
Int Psychogeriatr. 2012 Jul;24(7):1034-45. doi: 10.1017/S1041610211002924. Epub 2012 Feb 13.
2
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
3
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.初级保健医生对有症状人群进行全因痴呆或认知障碍诊断的临床判断。
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2.
7
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.胆碱酯酶抑制剂治疗血管性痴呆和其他血管性认知障碍:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

1
Multimorbidity in dementia: Current perspectives and future challenges.痴呆症中的多重疾病:当前观点与未来挑战。
Alzheimers Dement. 2025 Aug;21(8):e70546. doi: 10.1002/alz.70546.
2
Sex and gender differences in access, quality of care, and effectiveness of treatment in dementia: a scoping review of studies up to 2024.痴呆症在获得医疗服务、护理质量和治疗效果方面的性别差异:截至2024年的研究范围综述
Arch Public Health. 2025 May 29;83(1):139. doi: 10.1186/s13690-025-01626-z.
3
A multinational cohort study of trends in survival following dementia diagnosis.
一项关于痴呆症诊断后生存趋势的跨国队列研究。
Commun Med (Lond). 2025 May 28;5(1):203. doi: 10.1038/s43856-025-00923-6.
4
Survival outcomes among hospitalized patients with dementia: a propensity score matching analysis.痴呆症住院患者的生存结局:倾向评分匹配分析
Acta Neurol Belg. 2025 Mar 15. doi: 10.1007/s13760-025-02746-7.
5
Gut microbiota may affect Alzheimer's disease through synaptic function mediated by CAMs pathway: A study combining Mendelian randomization and bioinformatics.肠道微生物群可能通过细胞粘附分子(CAMs)途径介导的突触功能影响阿尔茨海默病:一项结合孟德尔随机化和生物信息学的研究
J Alzheimers Dis Rep. 2025 Jan 13;9:25424823241310719. doi: 10.1177/25424823241310719. eCollection 2025 Jan-Dec.
6
Time to nursing home admission and death in people with dementia: systematic review and meta-analysis.痴呆症患者入住养老院及死亡的时间:系统评价与荟萃分析。
BMJ. 2025 Jan 8;388:e080636. doi: 10.1136/bmj-2024-080636.
7
Development and validation of a clinical prediction tool to estimate survival in community-dwelling adults living with dementia: a protocol.开发和验证一种用于估计社区居住的痴呆症患者生存的临床预测工具的方案。
BMJ Open. 2024 Nov 17;14(11):e086231. doi: 10.1136/bmjopen-2024-086231.
8
Longevity in the South Carolina Alzheimer's disease registry.南卡罗来纳州阿尔茨海默病登记处的长寿情况。
Front Neurol. 2024 Aug 21;15:1425495. doi: 10.3389/fneur.2024.1425495. eCollection 2024.
9
2024 Alzheimer's disease facts and figures.2024 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30.
10
Predictors for survival in patients with Alzheimer's disease: a large comprehensive meta-analysis.阿尔茨海默病患者生存的预测因素:一项大型综合荟萃分析。
Transl Psychiatry. 2024 Apr 10;14(1):184. doi: 10.1038/s41398-024-02897-w.